Horn L, Spiegel R, Gettinger SN et al. Clinical activity, safety and predictive biomarkers of the engineered antibody MPDL3280 (anti -PD-L1) in non -small -cell lung cancer: update from a phase Ia study. J Clin Oncol 2015; 33 (suppl; abstr 8029) 39.